Merck & Co., Inc. (MRK) Shareholder Equity
- 2026-06-30: Common Stock, Value, IssuedUSD $1.79B; Additional Paid in Capital, Common StockUSD $44.95B; Treasury Stock, Common, ValueUSD $64.13B; Accumulated Other Comprehensive Income (Loss), Net of TaxUSD $-3.94B.
- 2026-03-31: Common Stock, Value, IssuedUSD $1.79B; Additional Paid in Capital, Common StockUSD $45.18B; Treasury Stock, Common, ValueUSD $63.75B; Accumulated Other Comprehensive Income (Loss), Net of TaxUSD $-4.06B.
- 2025-12-31: Common Stock, Value, IssuedUSD $1.79B; Additional Paid in Capital, Common StockUSD $45.03B; Treasury Stock, Common, ValueUSD $63.00B; Accumulated Other Comprehensive Income (Loss), Net of TaxUSD $-4.29B.
- 2025-09-30: Common Stock, Value, IssuedUSD $1.79B; Additional Paid in Capital, Common StockUSD $44.83B; Treasury Stock, Common, ValueUSD $61.80B; Accumulated Other Comprehensive Income (Loss), Net of TaxUSD $-5.20B.
Merck & Co., Inc. Shareholder Equity
Filed components and totals, with each concept and unit kept separate. Components can overlap; they are not added together. Missing disclosures remain (m). Original concept pages retain their detailed breakdowns and history.
| Period end | Common Stock, Value, Issued USD | Additional Paid in Capital, Common Stock USD | Treasury Stock, Common, Value USD | Accumulated Other Comprehensive Income (Loss), Net of Tax USD | Retained Earnings (Accumulated Deficit) USD | Stockholders' Equity Attributable to Parent USD | Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest USD | Treasury Stock, Common, Shares shares | Treasury Stock, Value, Acquired, Cost Method USD | Preferred Stock, Value, Issued USD | Additional Paid in Capital USD | Treasury Stock, Value USD | Accumulated Other Comprehensive Income (Loss), Foreign Currency Translation Adjustment, Net of Tax USD | AOCI, Debt Securities, Available-for-sale, Adjustment, after Tax USD | Accumulated Other Comprehensive (Income) Loss, Defined Benefit Plan, after Tax USD | APIC, Share-based Payment Arrangement, Increase for Cost Recognition USD | Treasury Stock, Shares, Acquired shares | Noncontrolling Interest, Increase from Sale of Parent Equity Interest USD | Noncontrolling Interest, Increase from Business Combination USD | Noncontrolling Interest, Decrease from Deconsolidation USD | Reclassification from Accumulated Other Comprehensive Income, Current Period, Net of Tax USD | Reclassification from Accumulated Other Comprehensive Income, Current Period, before Tax USD | Accumulated Other Comprehensive Income (Loss), Cumulative Changes in Net Gain (Loss) from Cash Flow Hedges, Effect Net of Tax USD | Adjustments to Additional Paid in Capital, Income Tax Benefit from Share-based Compensation USD | Treasury Stock, Shares shares |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $1.79B | $44.95B | $64.13B | $-3.94B | $63.27B | $41.93B | $41.98B | 1.11B | 3 month · $712.00M 6 month · $1.64B | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2026-03-31 | $1.79B | $45.18B | $63.75B | $-4.06B | $66.72B | $45.88B | $45.93B | 1.11B | 3 month · $925.00M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2025-12-31 | $1.79B | $45.03B | $63.00B | $-4.29B | $73.08B | $52.61B | $52.66B | 1.10B | 12 month · $5.08B | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2025-09-30 | $1.79B | $44.83B | $61.80B | $-5.20B | $72.23B | $51.85B | $51.91B | 1.09B | 3 month · $1.32B 9 month · $3.83B | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2025-06-30 | $1.79B | $44.64B | $60.49B | $-5.42B | $68.48B | $48.99B | $49.06B | 1.07B | 3 month · $1.34B 6 month · $2.51B | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2025-03-31 | $1.79B | $44.82B | $59.40B | $-4.96B | $66.10B | $48.34B | $48.40B | 1.06B | 3 month · $1.16B | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2024-12-31 | $1.79B | $44.70B | $58.30B | $-4.95B | $63.07B | $46.31B | $46.37B | 1.05B | 12 month · $1.31B | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2024-09-30 | $1.79B | $44.53B | $57.83B | $-5.37B | $61.38B | $44.50B | $44.56B | 1.05B | 3 month · $444.00M 9 month · $817.00M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2024-06-30 | $1.79B | $44.36B | $57.39B | $-5.36B | $60.19B | $43.58B | $43.65B | 1.04B | 3 month · $251.00M 6 month · $373.00M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2024-03-31 | $1.79B | $44.60B | $57.45B | $-5.27B | $56.70B | $40.36B | $40.42B | 1.04B | 3 month · $122.00M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2023-12-31 | $1.79B | $44.51B | $57.45B | $-5.16B | $53.90B | $37.58B | $37.63B | 1.05B | 12 month · $1.35B | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2023-09-30 | $1.79B | $44.36B | $57.07B | $-4.92B | $57.08B | $41.25B | $41.30B | 1.04B | 3 month · $466.00M 9 month · $953.00M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2023-06-30 | $1.79B | $44.22B | $56.61B | $-4.90B | $54.20B | $38.69B | $38.74B | 1.04B | 3 month · $338.00M 6 month · $487.00M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2023-03-31 | $1.79B | $44.47B | $56.58B | $-4.88B | $62.04B | $46.83B | $46.91B | 1.04B | 3 month · $149.00M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2022-12-31 | $1.79B | $44.38B | $56.49B | $-4.77B | $61.08B | $45.99B | $46.06B | 1.04B | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | 12 month · $359.00M | 12 month · $446.00M | (m) | (m) | (m) |
| 2022-09-30 | $1.79B | $44.24B | $56.76B | $-4.74B | $59.93B | $44.46B | $44.52B | 1.04B | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2022-06-30 | $1.79B | $44.12B | $56.77B | $-4.33B | $58.44B | $43.24B | $43.32B | 1.04B | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2022-03-31 | $1.79B | $44.27B | $57.06B | $-4.37B | $56.25B | $40.88B | $40.95B | 1.05B | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2021-12-31 | $1.79B | $44.24B | $57.11B | $-4.43B | $53.70B | $38.18B | $38.26B | 1.05B | 12 month · $840.00M | (m) | (m) | $57.11B | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | 12 month · $-516.00M | 12 month · $-658.00M | (m) | (m) | 1.05B |
| 2021-09-30 | $1.79B | $44.15B | (m) | $-4.59B | $51.69B | $35.79B | $35.86B | (m) | 3 month · $583.00M 9 month · $822.00M | (m) | (m) | $57.24B | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | 1.05B |
| 2021-06-30 | $1.79B | $44.04B | (m) | $-4.63B | $48.78B | $33.29B | $33.39B | (m) | 3 month · $239.00M 6 month · $239.00M | (m) | (m) | $56.68B | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | 1.04B |
| 2021-03-31 | $1.79B | $39.61B | (m) | $-6.62B | $48.89B | $26.95B | $27.04B | (m) | (m) | (m) | (m) | $56.72B | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | 1.05B |
| 2020-12-31 | $1.79B | $39.59B | (m) | $-6.63B | $47.36B | $25.32B | $25.40B | (m) | 12 month · $1.28B | (m) | (m) | $56.79B | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | 12 month · $-215.00M | 12 month · $-287.00M | (m) | (m) | 1.05B |
| 2020-09-30 | $1.79B | $39.49B | (m) | $-6.38B | $51.11B | $29.19B | $29.27B | (m) | 9 month · $1.28B | (m) | (m) | $56.81B | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | 1.05B |
| 2020-06-30 | $1.79B | $39.37B | (m) | $-6.39B | $49.72B | $27.64B | $27.74B | (m) | 6 month · $1.28B | (m) | (m) | $56.85B | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | 1.05B |
| 2020-03-31 | $1.79B | $39.70B | (m) | $-6.39B | $48.27B | $26.20B | $26.30B | (m) | 3 month · $1.28B | (m) | (m) | $57.16B | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | 1.05B |
| 2019-12-31 | $1.79B | $39.66B | (m) | $-6.19B | $46.60B | $25.91B | $26.00B | (m) | 12 month · $4.78B | (m) | (m) | $55.95B | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | 12 month · $199.00M | 12 month · $239.00M | (m) | (m) | 1.04B |
| 2019-09-30 | $1.79B | $39.56B | (m) | $-5.39B | $45.80B | $26.84B | $26.93B | (m) | 3 month · $1.41B 9 month · $3.73B | (m) | (m) | $54.92B | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | 1.03B |
| 2019-06-30 | $1.79B | $39.48B | (m) | $-5.36B | $45.30B | $27.64B | $27.74B | (m) | 3 month · $1.24B 6 month · $2.33B | (m) | (m) | $53.57B | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | 1.01B |
| 2019-03-31 | $1.79B | $38.77B | (m) | $-5.35B | $44.06B | $27.54B | $27.67B | (m) | 3 month · $1.09B | (m) | (m) | $51.74B | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | 994.03M |
| 2018-12-31 | $1.79B | $38.81B | (m) | $-5.54B | $42.58B | $26.70B | $26.88B | (m) | 12 month · $9.09B | (m) | (m) | $50.93B | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | 12 month · $-355.00M | 12 month · $-424.00M | (m) | (m) | 984.54M |
| 2018-09-30 | $1.79B | $39.76B | (m) | $-5.15B | $42.19B | $32.42B | $32.66B | (m) | 3 month · $996.00M 9 month · $3.16B | (m) | (m) | $46.17B | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | 918.36M |
| 2018-06-30 | $1.79B | $39.74B | (m) | $-5.12B | $41.52B | $32.53B | $32.77B | (m) | 3 month · $1.60B 6 month · $2.16B | (m) | (m) | $45.40B | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | 907.06M |
| 2018-03-31 | $1.79B | $39.87B | (m) | $-5.06B | $41.11B | $33.67B | $33.90B | (m) | 3 month · $566.00M | (m) | (m) | $44.04B | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | 884.62M |
| 2017-12-31 | $1.79B | $39.90B | (m) | $-4.91B | $41.35B | $34.34B | $34.57B | (m) | 12 month · $4.01B | (m) | (m) | $43.79B | (m) | (m) | (m) | (m) | (m) | (m) | 12 month · $7.00M | (m) | 12 month · $240.00M | 12 month · $315.00M | (m) | (m) | 880.49M |
| 2017-09-30 | $1.79B | $39.82B | (m) | $-4.95B | $43.70B | $38.25B | $38.50B | (m) | 3 month · $159.00M 9 month · $2.31B | (m) | (m) | $42.12B | (m) | (m) | (m) | (m) | (m) | (m) | 9 month · $25.00M | (m) | (m) | (m) | (m) | (m) | 850.70M |
| 2017-06-30 | $1.79B | $39.78B | (m) | $-5.09B | $45.05B | $39.46B | $39.71B | (m) | 6 month · $2.15B | (m) | (m) | $42.05B | (m) | (m) | (m) | (m) | (m) | (m) | 6 month · $25.00M | (m) | (m) | (m) | (m) | (m) | 849.97M |
| 2017-03-31 | $1.79B | $39.90B | (m) | $-5.08B | $44.39B | $39.84B | $40.09B | (m) | 3 month · $1.02B | (m) | (m) | $41.16B | (m) | (m) | (m) | (m) | (m) | (m) | 3 month · $25.00M | (m) | (m) | (m) | (m) | (m) | 836.67M |
| 2016-12-31 | $1.79B | $39.94B | (m) | $-5.23B | $44.13B | $40.09B | $40.31B | (m) | 12 month · $3.43B | (m) | (m) | $40.55B | (m) | (m) | (m) | (m) | (m) | (m) | 12 month · $124.00M | (m) | (m) | (m) | (m) | (m) | 828.37M |
| 2016-09-30 | $1.79B | $39.90B | (m) | $-4.25B | $46.03B | $43.74B | $43.96B | (m) | 9 month · $2.42B | (m) | (m) | $39.72B | (m) | (m) | (m) | (m) | (m) | (m) | 9 month · $124.00M | (m) | (m) | (m) | (m) | (m) | 815.44M |
| 2016-06-30 | $1.79B | $39.91B | (m) | $-4.09B | $45.12B | $43.36B | $43.45B | (m) | 6 month · $1.57B | (m) | (m) | $39.38B | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | 811.48M |
| 2016-03-31 | $1.79B | $40.15B | (m) | $-4.19B | $45.19B | $43.81B | $43.90B | (m) | 3 month · $913.00M | (m) | (m) | $39.12B | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | 807.55M |
| 2015-12-31 | $1.79B | $40.22B | (m) | $-4.15B | $45.35B | $44.68B | $44.77B | (m) | 12 month · $4.19B | (m) | (m) | $38.53B | (m) | (m) | (m) | (m) | (m) | (m) | (m) | 12 month · $75.00M | (m) | (m) | (m) | (m) | 795.98M |
| 2015-09-30 | $1.79B | $40.14B | (m) | $-4.57B | $45.66B | $45.59B | $45.68B | (m) | 9 month · $3.00B | (m) | (m) | $37.43B | (m) | (m) | (m) | (m) | (m) | (m) | (m) | 9 month · $76.00M | (m) | (m) | (m) | (m) | 774.87M |
| 2015-06-30 | $1.79B | $40.11B | (m) | $-4.33B | $45.10B | $46.45B | $46.64B | (m) | 6 month · $1.72B | (m) | (m) | $36.23B | (m) | (m) | (m) | (m) | (m) | 6 month · $45.00M | (m) | (m) | 3 month · $92.00M 6 month · $212.00M | 3 month · $144.00M 6 month · $317.00M | (m) | (m) | 753.15M |
| 2015-03-31 | $1.79B | $40.35B | (m) | $-4.17B | $45.69B | $47.77B | $47.92B | (m) | 3 month · $1.01B | (m) | (m) | $35.90B | (m) | (m) | (m) | (m) | (m) | 3 month · $5.00M | (m) | (m) | 3 month · $120.00M | 3 month · $173.00M | (m) | (m) | 748.72M |
| 2014-12-31 | $1.79B | $40.42B | (m) | $-4.32B | $46.02B | $48.65B | $48.79B | (m) | 12 month · $7.70B | (m) | (m) | $35.26B | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | 12 month · $17.00M | 12 month · $41.00M | (m) | (m) | 738.96M |
| 2014-09-30 | $1.79B | $40.34B | (m) | $-3.00B | $39.99B | $45.22B | $45.36B | (m) | 9 month · $6.08B | (m) | (m) | $33.90B | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | 3 month · $-2.00M 9 month · $-34.00M | 3 month · $5.00M 9 month · $-41.00M | (m) | (m) | 716.26M |
| 2014-06-30 | $1.79B | $40.20B | (m) | $-2.44B | $40.37B | $48.36B | $48.52B | (m) | 6 month · $3.41B | (m) | (m) | $31.55B | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | 3 month · $-30.00M 6 month · $-32.00M | 3 month · $-42.00M 6 month · $-46.00M | (m) | (m) | 677.39M |
| 2014-03-31 | $1.79B | $40.45B | (m) | $-2.18B | $39.66B | $49.98B | $52.56B | (m) | 3 month · $1.17B | (m) | (m) | $29.75B | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | 3 month · $-2.00M | 3 month · $-4.00M | (m) | (m) | 647.57M |
| 2013-12-31 | $1.79B | $40.51B | (m) | $-2.20B | $39.26B | $49.77B | $52.33B | (m) | 12 month · $6.52B | (m) | (m) | $29.59B | $-1.47B | $54.00M | $909.00M | (m) | (m) | (m) | (m) | (m) | 12 month · $-203.00M | 12 month · $-289.00M | $132.00M | 12 month · $61.00M | 649.58M |
| 2013-09-30 | $1.79B | $39.91B | (m) | $-4.70B | $39.77B | $47.42B | $50.01B | (m) | 9 month · $6.32B | (m) | (m) | $29.35B | $-1.40B | $36.00M | $3.41B | (m) | (m) | (m) | (m) | (m) | 3 month · $-52.00M 9 month · $-143.00M | 3 month · $-64.00M 9 month · $-205.00M | $72.00M | (m) | 650.49M |
| 2013-06-30 | $1.79B | $39.89B | (m) | $-4.76B | $39.91B | $47.50B | $50.10B | (m) | 6 month · $6.11B | (m) | (m) | $29.33B | $-1.47B | $-7.00M | $3.46B | (m) | (m) | (m) | (m) | (m) | 3 month · $-43.00M 6 month · $-91.00M | 3 month · $-65.00M 6 month · $-141.00M | $174.00M | (m) | 650.63M |
| 2013-03-31 | $1.79B | $40.73B | (m) | $-4.63B | $40.27B | $53.03B | $55.61B | (m) | 3 month · $580.00M | (m) | (m) | $25.13B | $-1.34B | $74.00M | $-3.51B | (m) | (m) | (m) | (m) | (m) | 3 month · $-48.00M | 3 month · $-76.00M | $139.00M | (m) | 559.73M |
| 2012-12-31 | $1.79B | $40.65B | (m) | $-4.68B | $39.98B | $53.02B | $55.46B | (m) | 12 month · $2.59B | (m) | (m) | $24.72B | $-991.00M | $73.00M | $3.67B | (m) | (m) | (m) | (m) | (m) | 12 month · $-89.00M | 12 month · $-156.00M | $-97.00M | 12 month · $94.00M | 550.47M |
| 2012-09-30 | $1.79B | $40.47B | (m) | $-3.04B | $40.39B | $55.75B | $58.21B | (m) | 9 month · $1.44B | (m) | (m) | $23.86B | $-727.00M | $83.00M | $2.30B | (m) | (m) | (m) | (m) | (m) | (m) | (m) | $-95.00M | (m) | 532.70M |
| 2012-06-30 | $1.79B | $40.55B | (m) | $-3.13B | $39.95B | $55.19B | $57.67B | (m) | 6 month · $985.00M | (m) | (m) | $23.97B | $-897.00M | $51.00M | $2.33B | (m) | (m) | (m) | (m) | (m) | (m) | (m) | $48.00M | (m) | 538.19M |
| 2012-03-31 | $1.79B | $40.65B | (m) | $-3.22B | $39.44B | $54.86B | $57.31B | (m) | 3 month · $456.00M | (m) | (m) | $23.80B | $-867.00M | $50.00M | $-2.35B | (m) | (m) | (m) | (m) | (m) | (m) | (m) | $-54.00M | (m) | 534.96M |
| 2011-12-31 | $1.79B | $40.66B | (m) | $-3.13B | $38.99B | $54.52B | $56.94B | (m) | 12 month · $1.92B | (m) | (m) | $23.79B | $-811.00M | $21.00M | $2.35B | (m) | (m) | (m) | (m) | (m) | (m) | (m) | $4.00M | (m) | 536.11M |
| 2011-09-30 | $1.79B | $40.72B | (m) | $-2.71B | $38.76B | $55.14B | $57.60B | (m) | 9 month · $1.36B | (m) | (m) | $23.41B | $-713.00M | $20.00M | $-1.98B | (m) | 9 month · 41.00M | (m) | (m) | (m) | (m) | (m) | $-36.00M | (m) | 525.00M |
| 2011-06-30 | $1.79B | $40.66B | (m) | $-2.78B | $38.24B | $55.50B | $57.92B | (m) | 6 month · $314.00M | (m) | (m) | $22.42B | $-691.00M | $26.00M | $2.02B | (m) | 6 month · 9.00M | (m) | (m) | (m) | (m) | (m) | $-96.00M | (m) | 493.94M |
| 2011-03-31 | $1.79B | $40.69B | (m) | $-3.17B | $37.40B | $54.38B | $56.84B | (m) | (m) | (m) | (m) | $22.32B | $-1.11B | $30.00M | $-2.02B | 3 month · $98.00M | (m) | (m) | (m) | (m) | (m) | (m) | $-66.00M | (m) | 491.66M |
| 2010-12-31 | $1.79B | $40.70B | (m) | $-3.22B | $37.54B | $54.38B | $56.80B | (m) | 12 month · $1.59B | (m) | (m) | $22.43B | $-1.25B | $31.00M | $2.04B | 12 month · $1.09B | (m) | (m) | (m) | (m) | (m) | (m) | $41.00M | (m) | 494.84M |
| 2010-09-30 | $1.79B | $40.56B | (m) | $-3.49B | $39.25B | $55.59B | $58.05B | (m) | 9 month · $1.59B | (m) | (m) | $22.51B | $-1.20B | $50.00M | $-2.33B | (m) | (m) | (m) | (m) | (m) | (m) | (m) | $-12.00M | (m) | 497.03M |
| 2010-06-30 | $1.79B | $40.34B | (m) | $-4.66B | $40.08B | $55.23B | $57.66B | (m) | 6 month · $1.30B | (m) | (m) | $22.32B | $-2.48B | $29.00M | $-2.35B | (m) | (m) | (m) | (m) | (m) | (m) | (m) | $137.00M | (m) | 491.66M |
| 2010-03-31 | $1.79B | $40.20B | (m) | $-3.57B | $40.51B | $57.88B | $60.34B | (m) | (m) | (m) | (m) | $21.04B | $-1.22B | $27.00M | $-2.41B | 3 month · $519.00M | (m) | (m) | (m) | (m) | (m) | (m) | $26.00M | (m) | 454.31M |
| 2009-12-31 | $1.78B | $39.68B | (m) | $-2.77B | $41.41B | $59.06B | $61.48B | (m) | (m) | (m) | (m) | $21.04B | $-289.00M | $33.00M | $-2.47B | 12 month · $558.00M | (m) | (m) | (m) | (m) | (m) | (m) | $-42.00M | (m) | 454.31M |
| 2009-09-30 | $1.07B | (m) | (m) | $-1.36B | $10.74B | $12.90B | $25.35B | (m) | (m) | $2.50B | $5.34B | $5.38B | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | 493.00M |
| 2009-06-30 | $1.06B | (m) | (m) | $-1.71B | $10.37B | $12.04B | $22.74B | (m) | (m) | $2.50B | $5.20B | $5.38B | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | 493.00M |
| 2008-12-31 | $29.80M | $8.32B | (m) | $-2.55B | $43.70B | $18.76B | $21.17B | (m) | 12 month · $2.73B | $2.50B | $5.04B | $30.74B | (m) | (m) | (m) | 12 month · $469.00M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | 875.82M |
| 2007-12-31 | (m) | (m) | (m) | (m) | (m) | (m) | $20.59B | (m) | 12 month · $-1.43B | (m) | (m) | (m) | (m) | (m) | (m) | 12 month · $1.30B | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2006-12-31 | (m) | (m) | (m) | (m) | (m) | (m) | $19.97B | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| AbbVie Inc. (ABBV) | United States | $468.180B | 70.37 |
| ABBOTT LABORATORIES (ABT) | United States | $176.045B | 28.47 |
| PFIZER INC (PFE) | United States | $162.042B | 31.94 |
| VERTEX PHARMACEUTICALS INC / MA (VRTX) | United States | $132.481B | 28.56 |
| BRISTOL MYERS SQUIBB CO (BMY) | United States | $125.637B | 12.67 |
| JOHNSON & JOHNSON (JNJ) | United States | $652.528B | 29.10 |
| REGENERON PHARMACEUTICALS, INC. (REGN) | United States | $74.751B | 21.53 |
| ALNYLAM PHARMACEUTICALS, INC. (ALNY) | United States | $33.420B | 54.94 |
| Zoetis Inc. (ZTS) | United States | $29.045B | 11.38 |
| INSMED Inc (INSM) | United States | $26.566B | -26.60 |